These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
4. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies. Puangmalai N; Bhatt N; Montalbano M; Sengupta U; Gaikwad S; Ventura F; McAllen S; Ellsworth A; Garcia S; Kayed R Cell Death Dis; 2020 May; 11(5):314. PubMed ID: 32366836 [TBL] [Abstract][Full Text] [Related]
5. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains. Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795 [TBL] [Abstract][Full Text] [Related]
6. Tauopathies and tau oligomers. Takashima A J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895 [TBL] [Abstract][Full Text] [Related]
7. Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology. Gratuze M; Julien J; Petry FR; Morin F; Planel E Sci Rep; 2017 Apr; 7():46359. PubMed ID: 28402338 [TBL] [Abstract][Full Text] [Related]
8. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies. Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231 [TBL] [Abstract][Full Text] [Related]
9. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains. Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118 [TBL] [Abstract][Full Text] [Related]
10. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology. Sepulveda-Diaz JE; Alavi Naini SM; Huynh MB; Ouidja MO; Yanicostas C; Chantepie S; Villares J; Lamari F; Jospin E; van Kuppevelt TH; Mensah-Nyagan AG; Raisman-Vozari R; Soussi-Yanicostas N; Papy-Garcia D Brain; 2015 May; 138(Pt 5):1339-54. PubMed ID: 25842390 [TBL] [Abstract][Full Text] [Related]
11. STOX1A induces phosphorylation of tau proteins at epitopes hyperphosphorylated in Alzheimer's disease. van Abel D; Abdulhamid O; Scheper W; van Dijk M; Oudejans CB Neurosci Lett; 2012 Oct; 528(2):104-9. PubMed ID: 22995177 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. Ferrer I; Blanco R; Carmona M; Puig B J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. Mailliot C; Sergeant N; Bussière T; Caillet-Boudin ML; Delacourte A; Buée L FEBS Lett; 1998 Aug; 433(3):201-4. PubMed ID: 9744794 [TBL] [Abstract][Full Text] [Related]
14. Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease. Yanagisawa M; Planel E; Ishiguro K; Fujita SC FEBS Lett; 1999 Nov; 461(3):329-33. PubMed ID: 10567721 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease. An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979 [TBL] [Abstract][Full Text] [Related]
16. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies. Yarchoan M; Toledo JB; Lee EB; Arvanitakis Z; Kazi H; Han LY; Louneva N; Lee VM; Kim SF; Trojanowski JQ; Arnold SE Acta Neuropathol; 2014 Nov; 128(5):679-89. PubMed ID: 25107476 [TBL] [Abstract][Full Text] [Related]
17. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies]. Joly-Amado A; Gratuze M; Benderradji H; Vieau D; Buée L; Blum D Med Sci (Paris); 2018 Nov; 34(11):929-935. PubMed ID: 30526837 [TBL] [Abstract][Full Text] [Related]
18. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils. Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461 [TBL] [Abstract][Full Text] [Related]
19. [Neuropathology of tauopathy]. Yoshida M Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931 [TBL] [Abstract][Full Text] [Related]